Publications by authors named "Michael Dolph"

Claim this Profile
S
Survival trends using DPd vs. other triplets in early RRMM patients: a population-adjusted indirect treatment comparison.
Faiz Anwer, Tommy Lan, Michael Dolph, Hoora Moradian, Samantha Slaff

Future Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial.
Michael Dolph, Gabriel Tremblay, Hoyee Leong

Pharmacoeconomics· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma.
Michael Dolph, Gabriel Tremblay, Adrienne M Gilligan, Hoyee Leong

J Health Econ Outcomes Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised trial of nutrient supplements to minimise psychological stress after a natural disaster.
Bonnie J Kaplan, Julia J Rucklidge, Amy R Romijn, Michael Dolph

Psychiatry Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.
Kuo-Cheng Huang, Mohammed Alshalalfa, Samar A Hegazy, Michael Dolph, Bryan Donnelly

Cancer Biol Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis.
Samir Al Bashir, Mohammed Alshalalfa, Samar A Hegazy, Michael Dolph, Bryan Donnelly

J Hematol Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome.
Tarek A Bismar, Mohammed Alshalalfa, Lars F Petersen, Liang Hong Teng, Travis Gerke, Michael Dolph

BJU Int· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.
Bin Xu, Liang Hong Teng, Sabrina Daniela da Silva, Krikor Bijian, Samir Al Bashir, Michael Dolph

Cancer Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer.
Liang Hong Teng, Cheng Wang, Michael Dolph, Bryan Donnelly, Tarek A Bismar

ISRN Urol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.
Liang-Hong Teng, Cheng Wang, Louis R Bégin, Michael Dolph, Asli Yilmaz

Urology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality.
Tarek A Bismar, Michael Dolph, Liang-Hong Teng, Shuhong Liu, Bryan Donnelly

Eur J Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis